Comparison between Par Drugs IPO and Suich Industries IPO.
Par Drugs IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Suich Industries IPO is a SME Bookbuilding proposed to list at BSE SME.
| Par Drugs IPO | Suich Industries IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Bookbuilding |
| Listing At | NSE SME | BSE SME |
| Lead Managers | Pantomath Capital Advisors Pvt.Ltd. | Pantomath Capital Advisors Pvt.Ltd. |
| Registrar | MUFG Intime India Pvt.Ltd. | MUFG Intime India Pvt.Ltd. |
| Market Maker | Pantomath Stock Brokers Pvt.Ltd. | Pantomath Stock Brokers Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Par Drugs IPO is up to ₹8.10 Cr whereas the issue size of the Suich Industries IPO is up to ₹29.30 Cr. The final issue price of Par Drugs IPO is ₹51.00 per share and of Suich Industries IPO is ₹75.00 per share.
| Par Drugs IPO | Suich Industries IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹73.00 per share | |
| Issue Price (Upper) | ₹75.00 per share | |
| Issue Price (Final) | ₹51.00 per share | ₹75.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹0.00 per share | |
| Market Lot Size | 2000 shares | 1600 shares |
| Fresh Issue Size | 15,88,000 shares | 39,07,200 shares |
| Fresh Issue Size (Amount) | up to ₹8.10 Cr | up to ₹29.30 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 15,88,000 shares | 39,07,200 shares |
| Issue Size Total (Amount) | up to ₹8.10 Cr | up to ₹29.30 Cr |
Par Drugs IPO opens on May 03, 2019, while Suich Industries IPO opens on May 30, 2019. The closing date of Par Drugs IPO and Suich Industries IPO is May 08, 2019, and Jun 04, 2019, respectively.
| Par Drugs IPO | Suich Industries IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | May 03, 2019 | May 30, 2019 |
| Issue Close | May 08, 2019 | Jun 04, 2019 |
| Basis Of Allotment (Tentative) | May 13, 2019 | Jun 10, 2019 |
| Initiation of Refunds (Tentative) | May 14, 2019 | Jun 11, 2019 |
| Credit of Share (Tentative) | May 15, 2019 | Jun 12, 2019 |
| Listing date (Tentative) | May 16, 2019 | Jun 13, 2019 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Par Drugs IPO P/E ratio is , as compared to Suich Industries IPO P/E ratio of .
| Par Drugs IPO | Suich Industries IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 99.55 | 95.50 | ||||
| Promoter Shareholding (Post-Issue) | 72.82 | 69.72 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹31.38 Cr. | ₹114.33 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the Par Drugs IPO Retail Individual Investors (RII) are offered 7,80,000 shares while in Suich Industries IPO retail investors are offered 7,80,000 shares. Qualified Institutional Buyers (QIB) are offered in Par Drugs IPO and in Suich Industries IPO.
| Par Drugs IPO | Suich Industries IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | 84,000 shares | 2,08,000 shares |
| QIB | ||
| NII | 7,78,000 shares | 19,52,000 shares |
| RII | 7,80,000 shares | 19,55,200 shares |
| Employee | 30,000 shares | |
| Others | ||
| Total | 15,88,000 shares | 39,07,200 shares |
Par Drugs IPO subscribed 5.64x in total, whereas Suich Industries IPO subscribed 1.39x.
| Par Drugs IPO | Suich Industries IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 3.48x | 1.32x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 7.97x | 1.47x |
| Employee (times) | 1.00x | |
| Other (times) | ||
| Total (times) | 5.64x | 1.39x |
